OPEN Cancers | 3 May 2014
V Beylergil and JA Carrasquillo
Several molecular imaging modalities have been evaluated in the management of Merkel cell carcinoma (MCC), a rare and aggressive tumor with a high tendency to metastasize. Continuous progress in the field of molecular imaging might improve management in these patients. The authors review the current modalities and their impact on MCC in this brief review article.
* Data courtesy of Altmetric.com